KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Health Services (UHS) Cash from Financing Activities (2016 - 2025)

Universal Health Services (UHS) has disclosed Cash from Financing Activities for 17 consecutive years, with -$296.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 30.61% year-over-year to -$296.1 million, compared with a TTM value of -$749.7 million through Dec 2025, up 34.51%, and an annual FY2025 reading of -$749.7 million, up 34.51% over the prior year.
  • Cash from Financing Activities was -$296.1 million for Q4 2025 at Universal Health Services, down from -$134.5 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $154.0 million in Q2 2022 and bottomed at -$426.8 million in Q4 2024.
  • Average Cash from Financing Activities over 5 years is -$188.8 million, with a median of -$195.6 million recorded in 2023.
  • The sharpest move saw Cash from Financing Activities surged 139.29% in 2022, then crashed 1085.95% in 2023.
  • Year by year, Cash from Financing Activities stood at -$132.9 million in 2021, then surged by 88.44% to -$15.4 million in 2022, then plummeted by 1085.95% to -$182.3 million in 2023, then tumbled by 134.08% to -$426.8 million in 2024, then surged by 30.61% to -$296.1 million in 2025.
  • Business Quant data shows Cash from Financing Activities for UHS at -$296.1 million in Q4 2025, -$134.5 million in Q3 2025, and -$227.7 million in Q2 2025.